You are subscribed to the Drug Topics Hospital Pharmacists' Report.

Drug Topics Hospital Pharmacists' Report

eNewsletter Subscribe

Print Subscribe

Digital Edition Subscribe

July 10, 2014

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TODAY'S HEADLINES

IV insulin, anticoagulants top high-alert meds' list

Pharmacists, nurses, and other practitioners believe IV insulin and anticoagulants should be considered the most high-alert medications – those that can cause the most patient harm when used improperly – according to a new survey. » More

Top Stories of the Month

We all know that electronic prescriptions solved all those script communication problems between prescribers and pharmacists, right? Well, the Cynical Pharmacist dispelled any such myths in his blog "Electronic prescriptions: Return to sender." It was our most-read story of June. » More

California pharmacists to furnish naloxone?

A bill that would authorize California pharmacists to dispense naloxone hydrochloride, a drug used to reverse opiate overdoses, has cleared several legislative hurdles. » More

Pill-mill crackdown cut Florida's overdose deaths

A federal report credits Florida's crackdown on pill mills and doctor shoppers with reducing deaths from prescription-drug overdoses by nearly one quarter. The report from the Centers for Disease Control and Prevention documents a 23% reduction in prescription drug deaths in Florida from 2010 to 2012. » More

Continuing Education

MTM essentials for antiplatelet therapy in cardiovascular disease

This month's article is the sixth in a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to review the pharmacokinetic and pharmacodynamic differences, clinical indications, and pertinent drug-drug interactions for antiplatelet agents in cardiovascular disease.

To read and print the article with TEST QUESTIONS, click here.To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 14DT08-KTF27.

Announcement: Starting this month, our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/.

 
Advertisement

Check these out, too

'Intelligent Pharmacy Pavilion' at ASHP

FDA approves treatment for PTCL

Vial misuse harming thousands of patients

California mulling Rx mail-order opt-out

Voices

Anticoagulation Update

JP at Large

View from the Zoo

Viewpoints

Regulatory and Legal

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group